Marc S Rendell. Expert Rev Endocrinol Metab 2018
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes.
Santhosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, Dipshikha Biswas, Craig Boyle, Samuel Chackalamannil, Yan Xia, Charles Jayne, Bernard Neustadt, Jinsong Hao,[...]. ACS Med Chem Lett 2018
Santhosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, Dipshikha Biswas, Craig Boyle, Samuel Chackalamannil, Yan Xia, Charles Jayne, Bernard Neustadt, Jinsong Hao,[...]. ACS Med Chem Lett 2018
50
Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.
Stefania Carobbio, Vanessa Pellegrinelli, Antonio Vidal-Puig. Adv Exp Med Biol 2017
Stefania Carobbio, Vanessa Pellegrinelli, Antonio Vidal-Puig. Adv Exp Med Biol 2017
33
Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.
Mohsen Janghorbani, Masoud Amini. Ann Nutr Metab 2016
Mohsen Janghorbani, Masoud Amini. Ann Nutr Metab 2016
33
Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine.
Jens Nielsen. Cell Metab 2017
Jens Nielsen. Cell Metab 2017
33
Continuous and Dichotomous Metabolic Syndrome Definitions in Youth Predict Adult Type 2 Diabetes and Carotid Artery Intima Media Thickness: The Cardiovascular Risk in Young Finns Study.
Costan G Magnussen, Sanith Cheriyan, Matthew A Sabin, Markus Juonala, Juha Koskinen, Russell Thomson, Michael R Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen,[...]. J Pediatr 2016
Costan G Magnussen, Sanith Cheriyan, Matthew A Sabin, Markus Juonala, Juha Koskinen, Russell Thomson, Michael R Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen,[...]. J Pediatr 2016
33
Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Seyed Mohammad Riahi, Soraya Moamer, Mahshid Namdari, Yaser Mokhayeri, Mohammad Amin Pourhoseingholi, Seyed Saeed Hashemi-Nazari. Int J Cardiol 2018
Seyed Mohammad Riahi, Soraya Moamer, Mahshid Namdari, Yaser Mokhayeri, Mohammad Amin Pourhoseingholi, Seyed Saeed Hashemi-Nazari. Int J Cardiol 2018
33
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
33
Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study.
Farahnaz Salehinia, Hengameh Abdi, Farzad Hadaegh, Sara Serahati, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah. Diabetes Res Clin Pract 2018
Farahnaz Salehinia, Hengameh Abdi, Farzad Hadaegh, Sara Serahati, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah. Diabetes Res Clin Pract 2018
33
American College of Endocrinology position statement on the insulin resistance syndrome.
Daniel Einhorn, Gerald M Reaven, Rhoda H Cobin, Earl Ford, Om P Ganda, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, David Kendall, Ronald M Krauss,[...]. Endocr Pract 2003
Daniel Einhorn, Gerald M Reaven, Rhoda H Cobin, Earl Ford, Om P Ganda, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, David Kendall, Ronald M Krauss,[...]. Endocr Pract 2003
33
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.
Siegfried Ussar, Shiho Fujisaka, C Ronald Kahn. Mol Metab 2016
Siegfried Ussar, Shiho Fujisaka, C Ronald Kahn. Mol Metab 2016
33
33
Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ.
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang, Luyong Zhang. Eur J Med Chem 2018
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang, Luyong Zhang. Eur J Med Chem 2018
33
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.
M Angelyn Bethel, Rishi A Patel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Robert J Mentz, Neha J Pagidipati, Juliana C Chan, Stephanie M Gustavson, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2018
M Angelyn Bethel, Rishi A Patel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Robert J Mentz, Neha J Pagidipati, Juliana C Chan, Stephanie M Gustavson, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2018
33
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)
B Balkau, M A Charles. Diabet Med 1999
B Balkau, M A Charles. Diabet Med 1999
33
Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program.
Mark D DeBoer, Stephanie L Filipp, Matthew J Gurka. Diabetes Care 2018
Mark D DeBoer, Stephanie L Filipp, Matthew J Gurka. Diabetes Care 2018
33
Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis.
H Hussein, F Zaccardi, K Khunti, S Seidu, M J Davies, L J Gray. Diabet Med 2019
H Hussein, F Zaccardi, K Khunti, S Seidu, M J Davies, L J Gray. Diabet Med 2019
33
Browning of white adipose tissue: lessons from experimental models.
Thereza Cristina Lonzetti Bargut, Vanessa Souza-Mello, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. Horm Mol Biol Clin Investig 2017
Thereza Cristina Lonzetti Bargut, Vanessa Souza-Mello, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. Horm Mol Biol Clin Investig 2017
33
Design and validation of a population-based definition of the metabolic syndrome.
Carlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, Francisco J Gómez-Pérez, Roopa Mehta, Gustavo Olaiz, Juan A Rull, David R Cox. Diabetes Care 2006
Carlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, Francisco J Gómez-Pérez, Roopa Mehta, Gustavo Olaiz, Juan A Rull, David R Cox. Diabetes Care 2006
33
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Clair Crewe, Yu Aaron An, Philipp E Scherer. J Clin Invest 2017
Clair Crewe, Yu Aaron An, Philipp E Scherer. J Clin Invest 2017
33
Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function.
Zhengtao Liu, Cheng Zhang, Sunjae Lee, Woonghee Kim, Martina Klevstig, Azadeh M Harzandi, Natasa Sikanic, Muhammad Arif, Marcus Ståhlman, Jens Nielsen,[...]. Metab Eng 2019
Zhengtao Liu, Cheng Zhang, Sunjae Lee, Woonghee Kim, Martina Klevstig, Azadeh M Harzandi, Natasa Sikanic, Muhammad Arif, Marcus Ståhlman, Jens Nielsen,[...]. Metab Eng 2019
33
Metabolic syndrome: definitions and controversies.
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
33
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.
K G M M Alberti, P Zimmet, J Shaw. Diabet Med 2006
K G M M Alberti, P Zimmet, J Shaw. Diabet Med 2006
33
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
K G Alberti, P Z Zimmet. Diabet Med 1998
K G Alberti, P Z Zimmet. Diabet Med 1998
33
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery.
Sten Madsbad, Carsten Dirksen, Jens J Holst. Lancet Diabetes Endocrinol 2014
Sten Madsbad, Carsten Dirksen, Jens J Holst. Lancet Diabetes Endocrinol 2014
33
Childhood obesity: a systems medicine approach.
William L Stone, Karen Schetzina, Charles Stuart. Front Biosci (Landmark Ed) 2016
William L Stone, Karen Schetzina, Charles Stuart. Front Biosci (Landmark Ed) 2016
50
33
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.
Varman T Samuel, Gerald I Shulman. J Clin Invest 2016
Varman T Samuel, Gerald I Shulman. J Clin Invest 2016
33
A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha Ambwani, Surjit Singh. Indian J Clin Biochem 2018
Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha Ambwani, Surjit Singh. Indian J Clin Biochem 2018
33
Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis.
Ying-Bin Hu, Xin-Yu Liu, Wei Zhan. Drug Des Devel Ther 2018
Ying-Bin Hu, Xin-Yu Liu, Wei Zhan. Drug Des Devel Ther 2018
33
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
Florencia Halperin, Su-Ann Ding, Donald C Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster,[...]. JAMA Surg 2014
Florencia Halperin, Su-Ann Ding, Donald C Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster,[...]. JAMA Surg 2014
33
Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis.
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
33
Regulation of hepatic glucose metabolism in health and disease.
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
33
Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.
Juan de Toro-Martín, Benoit J Arsenault, Jean-Pierre Després, Marie-Claude Vohl. Nutrients 2017
Juan de Toro-Martín, Benoit J Arsenault, Jean-Pierre Després, Marie-Claude Vohl. Nutrients 2017
33
Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
Tze Pin Ng, Liang Feng, Ma Shwe Zin Nyunt, Lei Feng, Qi Gao, May Li Lim, Simon L Collinson, Mei Sian Chong, Wee Shiong Lim, Tih Shih Lee,[...]. JAMA Neurol 2016
Tze Pin Ng, Liang Feng, Ma Shwe Zin Nyunt, Lei Feng, Qi Gao, May Li Lim, Simon L Collinson, Mei Sian Chong, Wee Shiong Lim, Tih Shih Lee,[...]. JAMA Neurol 2016
33
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A van Vliet, Alejandro Dorenbaum, Melissa Palmer. BMC Gastroenterol 2018
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A van Vliet, Alejandro Dorenbaum, Melissa Palmer. BMC Gastroenterol 2018
33
Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
Matthew J Gurka, Stephanie L Filipp, Thomas A Pearson, Mark D DeBoer. J Am Heart Assoc 2018
Matthew J Gurka, Stephanie L Filipp, Thomas A Pearson, Mark D DeBoer. J Am Heart Assoc 2018
33
Regulation of metabolism by the innate immune system.
Denise E Lackey, Jerrold M Olefsky. Nat Rev Endocrinol 2016
Denise E Lackey, Jerrold M Olefsky. Nat Rev Endocrinol 2016
33
Targeting inflammation in metabolic syndrome.
Francine K Welty, Abdulhamied Alfaddagh, Tarec K Elajami. Transl Res 2016
Francine K Welty, Abdulhamied Alfaddagh, Tarec K Elajami. Transl Res 2016
33
Metabolically healthy obesity: definitions, determinants and clinical implications.
Catherine M Phillips. Rev Endocr Metab Disord 2013
Catherine M Phillips. Rev Endocr Metab Disord 2013
33
Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
Matthias Blüher. Clin Sci (Lond) 2016
Matthias Blüher. Clin Sci (Lond) 2016
33
Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
Guo-Dong Kang, Lu Guo, Zhi-Rong Guo, Xiao-Shu Hu, Ming Wu, Hai-Tao Yang. Asia Pac J Clin Nutr 2012
Guo-Dong Kang, Lu Guo, Zhi-Rong Guo, Xiao-Shu Hu, Ming Wu, Hai-Tao Yang. Asia Pac J Clin Nutr 2012
33
Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery.
Nadejda Bozadjieva, Kristy M Heppner, Randy J Seeley. Diabetes 2018
Nadejda Bozadjieva, Kristy M Heppner, Randy J Seeley. Diabetes 2018
33
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
Scott M Grundy, James I Cleeman, Stephen R Daniels, Karen A Donato, Robert H Eckel, Barry A Franklin, David J Gordon, Ronald M Krauss, Peter J Savage, Sidney C Smith,[...]. Circulation 2005
Scott M Grundy, James I Cleeman, Stephen R Daniels, Karen A Donato, Robert H Eckel, Barry A Franklin, David J Gordon, Ronald M Krauss, Peter J Savage, Sidney C Smith,[...]. Circulation 2005
33
Medical Nutrition Education, Training, and Competencies to Advance Guideline-Based Diet Counseling by Physicians: A Science Advisory From the American Heart Association.
Karen E Aspry, Linda Van Horn, Jo Ann S Carson, Judith Wylie-Rosett, Robert F Kushner, Alice H Lichtenstein, Stephen Devries, Andrew M Freeman, Allison Crawford, Penny Kris-Etherton. Circulation 2018
Karen E Aspry, Linda Van Horn, Jo Ann S Carson, Judith Wylie-Rosett, Robert F Kushner, Alice H Lichtenstein, Stephen Devries, Andrew M Freeman, Allison Crawford, Penny Kris-Etherton. Circulation 2018
33
33
Metabolic Syndrome: Systems Thinking in Heart Disease.
Ron Dommermuth, Kristine Ewing. Prim Care 2018
Ron Dommermuth, Kristine Ewing. Prim Care 2018
33
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
S O'Neill, L O'Driscoll. Obes Rev 2015
S O'Neill, L O'Driscoll. Obes Rev 2015
33
The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data.
Alison J Dunkley, Melanie J Davies, Margaret A Stone, Nicholas A Taub, Jacqui Troughton, Thomas Yates, Kamlesh Khunti. Trials 2011
Alison J Dunkley, Melanie J Davies, Margaret A Stone, Nicholas A Taub, Jacqui Troughton, Thomas Yates, Kamlesh Khunti. Trials 2011
33
Food and Drug Administration's Obesity Drug Guidance Document: a short history.
Eric Colman. Circulation 2012
Eric Colman. Circulation 2012
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.